My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Merus N.V. - Common Shares (NQ:MRUS)

90.00 UNCHANGED

Last Price Updated: 4:00 PM EST, Dec 29, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Merus N.V. - Common Shares

< Previous 1 2 3 4 Next >

Where Merus Stands With Analysts ↗

August 10, 2023

Via Benzinga

Expert Ratings for Merus ↗

July 24, 2023

Via Benzinga

Analyst Expectations for Merus's Future ↗

June 30, 2023

Via Benzinga

7 Stocks That Wall Street Analysts Are Loving in May ↗

May 21, 2023

Though not perfect, an analyst rating can indicate where institutional investor sentiment lies; here are seven stocks that analysts love.

Via InvestorPlace

Where Merus Stands With Analysts ↗

May 18, 2023

Via Benzinga

Recap: Merus Q1 Earnings ↗

May 04, 2023

Via Benzinga

Analyst Boosts Merus Price Target As AACR Updates Meaningfully De-Risk Its Head & Cancer Therapy ↗

April 18, 2023

Via Benzinga

Ericsson, Johnson & Johnson, Goldman Sachs And Other Big Stocks Moving Lower On Tuesday ↗

April 18, 2023

U.S. stocks traded lower, with the Dow Jones dropping over 100 points on Tuesday. Here are some big stocks recording losses in today’s session.

Via Benzinga

The Latest Analyst Ratings for Merus ↗

April 05, 2023

Via Benzinga

4 Analysts Have This to Say About Merus ↗

March 01, 2023

Via Benzinga

Why Glory Star New Media Group Shares Are Trading Higher By 122%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

April 18, 2023

Gainers Glory Star New Media Group Holdings Limited (NASDAQ: GSMG) shares jumped 122% to $1.07 after the company announced the signing of a $60 million strategic investment with two institutional...

Via Benzinga

Merus' Petosemtamab Abstract Hits Upside Scenario For Overall Response Rate, Duration Of Response: Analyst ↗

April 14, 2023

Via Benzinga

What To Expect When Merus Presents Petosemtamab Data Update At AACR ↗

April 06, 2023

Via Benzinga

Merus Earnings Perspective: Return On Capital Employed ↗

November 24, 2022

Via Benzinga

5 Analysts Have This to Say About Merus ↗

November 16, 2022

Via Benzinga

What 4 Analyst Ratings Have To Say About Merus ↗

October 13, 2022

Within the last quarter, Merus (NASDAQ:MRUS) has observed the following analyst ratings:

Via Benzinga

4 Analysts Have This to Say About Merus ↗

October 13, 2022

Within the last quarter, Merus (NASDAQ:MRUS) has observed the following analyst ratings:

Via Benzinga

The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector ↗

March 15, 2023

To play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy.

Via InvestorPlace

Why Tivic Health Systems Are Trading Lower By 55%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

February 09, 2023

Gainers Hempacco Co., Inc. (NASDAQ: HPCO) rose 296% to $2.99 after declining 6% on Wednesday.

Via Benzinga

MGM Resorts, Madison Square Garden Entertainment, Cardiovascular Systems And Other Big Stocks Moving Higher On Thursday ↗

February 09, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Thursday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Why Lincoln National Shares Are Trading Lower By 31%? Here Are 72 Stocks Moving In Thursday's Session ↗

November 03, 2022

Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) gained 64% to $50.60.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023 ↗

January 05, 2023

Via Benzinga

Why Greenhill Shares Climbed Around 25%; Here Are 100 Biggest Movers From Yesterday ↗

November 04, 2022

Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) shares jumped 242.8% to close at $105.72 on Thursday. The company announced a strategic plan to enter into the clean energy industry.

Via Benzinga

Why New Oriental Education Shares Jumped Over 28%; Here Are 68 Biggest Movers From Yesterday ↗

October 27, 2022

Gainers ESSA Pharma Inc. (NASDAQ: EPIX) shares climbed 180.2% to close at $4.82 on Wednesday after the company highlighted updates results from the Phase 1/2 study of EPI-7386 with Enzalutamide At the...

Via Benzinga

Albemarle To Rally Around 8%? Here Are 5 Other Price Target Changes For Thursday ↗

October 13, 2022

Berenberg raised Albemarle Corporation (NYSE: ALB) price target from $260 to $270. Berenberg analyst Andres Castanos Mollor downgraded the stock from Buy to Hold. Albemarle shares fell 7.9% to close at...

Via Benzinga

Why Seagate Shares Are Trading Lower By More Than 7%? Here Are 49 Stocks Moving In Wednesday's Mid-Day Session ↗

October 26, 2022

Gainers ESSA Pharma Inc. (NASDAQ: EPIX) shares surged 59.3% to $2.7417 after the company highlighted updates results from the Phase 1/2 study of EPI-7386 with Enzalutamide At the 29th Annual Prostate...

Via Benzinga

Analyst Casts Doubts On Merus' Lung Candidate Safety Profile ↗

October 12, 2022

Earlier today, Merus N.V. (NASDAQ: MRUS) announced the publication of the abstract highlighting interim data from the ongoing phase 1/2 trial of the bispecific antibody MCLA-129 in advanced non-small...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2022 ↗

August 02, 2022

Upgrades

Via Benzinga

Merus Stock Joins Rank Of Stocks With RS Ratings Over 90 ↗

July 14, 2022

On Thursday, Netherlands-based Merus stock had its Relative Strength (RS) Rating upgraded to 94 from 78 a day earlier.

Via Investor's Business Daily

Needham Says Merus' ASCO Update On Zeno 'Positive' ↗

June 06, 2022

Needham writes that Merus NV (NASDAQ: MRUS) has enough data to initiate an FDA marketing application filing in mid-2022 after presenting Zenocutuzumab (Zeno) data in NRG1-fusion (NRG1+) Cancer.

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.